Search research articles
Contact Us
Filters
Showing results (1-10 of 8) with videos related to
Page
of 1
Sort By:
Hematology/Oncology Clinics of North America
|
June 30, 2022
Regulatory Aspects of Gene Therapy: The Regulatory Life Cycle
Najat Bouchkouj, Megha Kaushal, Poornima Sharma, et al.
Journal of Health Care for the Poor and Underserved
|
August 7, 2007
Outreach to immigrant communities: teaching pediatric residents about access to health care
Robert J Karp, David Rhee, David Feldman, et al.
The Oncologist
|
August 19, 2022
FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Najat Bouchkouj, Xue Lin, Xiaofei Wang, et al.
Journal of the National Cancer Institute
|
April 30, 2021
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective
Meena N Murugappan, Bellinda L King-Kallimanis, Gregory H Reaman, et al.
The Oncologist
|
April 11, 2022
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma
Najat Bouchkouj, Megan Zimmerman, Yvette L Kasamon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2018
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
Najat Bouchkouj, Yvette L Kasamon, R Angelo de Claro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy
Brynn B Duncan, Steven L Highfill, Haiying Qin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2021
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Claudia Rossig, Crystal Mackall, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 8) with videos related to
Sort By:
Page
of 1
Hematology/Oncology Clinics of North America
|
June 30, 2022
Regulatory Aspects of Gene Therapy: The Regulatory Life Cycle
Najat Bouchkouj, Megha Kaushal, Poornima Sharma, et al.
Journal of Health Care for the Poor and Underserved
|
August 7, 2007
Outreach to immigrant communities: teaching pediatric residents about access to health care
Robert J Karp, David Rhee, David Feldman, et al.
The Oncologist
|
August 19, 2022
FDA Approval Summary: Brexucabtagene Autoleucel for Treatment of Adults With Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia
Najat Bouchkouj, Xue Lin, Xiaofei Wang, et al.
Journal of the National Cancer Institute
|
April 30, 2021
Patient-Reported Outcomes in Pediatric Cancer Registration Trials: A US Food and Drug Administration Perspective
Meena N Murugappan, Bellinda L King-Kallimanis, Gregory H Reaman, et al.
The Oncologist
|
April 11, 2022
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma
Najat Bouchkouj, Megan Zimmerman, Yvette L Kasamon, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 11, 2018
FDA Approval Summary: Axicabtagene Ciloleucel for Relapsed or Refractory Large B-cell Lymphoma
Najat Bouchkouj, Yvette L Kasamon, R Angelo de Claro, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
September 3, 2013
A pan-inhibitor of DASH family enzymes induces immune-mediated regression of murine sarcoma and is a potent adjuvant to dendritic cell vaccination and adoptive T-cell therapy
Brynn B Duncan, Steven L Highfill, Haiying Qin, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 29, 2021
Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration
Andrew Dj Pearson, Claudia Rossig, Crystal Mackall, et al.
Page
of 1